Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.
Several research groups have developed experimental vaccine approaches that protect nonhuman primates from Ebola virus and the closely related Marburg virus. These approaches include vaccines based on DNA, recombinant adenovirus, virus-like particles, and human parainfluenza virus 3. But how these vaccine candidates confer protection is an area that is still being explored: Do they activate immune cells to kill the invading virus? Or do they elicit antibodies that block infection?
In this study, scientists at NIH's National Institute of Allergy and Infectious Diseases and OHSU's Vaccine & Gene Therapy Institute built on earlier work with an experimental vaccine composed of an attenuated vesicular stomatitis virus carrying a gene that codes for an Ebola virus protein. They observed how cynomolgus macaques responded to a challenge of Ebola virus before and during treatment with the vaccine and in conjunction with depleted levels of immune cells. Their results showed that important immune cells—CD4+ T cells and CD8+ T cells—had a minimal role in providing protection, while antibodies induced by the vaccine appeared to be critical to protecting the animals.
The scientists say this finding will help improve future Ebola virus vaccine development. They plan to focus their studies on what level of antibody production is needed to establish protection from Ebola virus infection in humans
WHO: Heinz Feldmann, M.D., Ph.D., chief of the Laboratory of Virology at NIAID's Rocky Mountain Laboratories. Dr. Feldmann is an expert on viral hemorrhagic fevers and emerging viruses.
ARTICLE: A Marzi et al. Antibodies are necessary for rVSV/ZEBOV-GP mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.1209591110 (2013).
NIH/National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
But adding small amounts of land to already protected areas could help save the island's biodiversity
The disease which has killed more than 8,000 people in the past year may be the number one threat to great apes in Africa
The Bulletin of Atomic Scientists Science and Security Board is warning that "the probability of global catastrophe is very high" unless quick action is taken.
Gregory Asner has loaded a plane with lasers, spectrometers and computers to create models so detailed, they distinguish between and count plant species in even the densest biomes, like the Amazon.
The smallest critters who occupy the bottom of the cold, clear waters of Lake Tahoe are dying off at an alarming rate and scientists are trying to find the cause to protect the fragile ecosystem of the lake high in the Sierra Nevada range.
In Russia’s Far East, an orphaned female tiger is the test case in an experimental effort to save one of the most endangered animals on earth
But look out for hazel catkins turning plump with pollen Continue reading...
Senators accept global warming is not a hoax but fail to recognise human activity is to blame, nearly 27 years after scientists laid out man’s role
United States Senators stood up for what they believed in today—and it wasn’t pretty.
China is about to announce the findings of its latest giant panda “National Survey”, a once-a-decade census that aims to put a figure on the number of giant pandas left in the wild. Will the figure be accurate?